• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胂凡纳明黄疸与器械传播病毒感染的识别

Arsphenamine jaundice and the recognition of instrument-borne virus infection.

作者信息

Mortimer P P

机构信息

Hepatitis and Retrovirus Laboratory, Virus Reference Division, London, UK.

出版信息

Genitourin Med. 1995 Apr;71(2):109-19. doi: 10.1136/sti.71.2.109.

DOI:10.1136/sti.71.2.109
PMID:7744400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1195466/
Abstract

Soon after its introduction in 1910, intravenous arsphenamine treatment for syphilis was found to be complicated by jaundice. The underlying cause, unsterile syringes and needles, was eventually recognised in the early 1940s, mainly through the efforts of British Army investigators. The infection most often transmitted was probably hepatitis B virus (HBV), but the high mortality in a few of the outbreaks of arsphenamine jaundice suggests that variants of HBV, or other hepatitis viruses, were sometimes involved. Fifty years later, at a time when there are estimated to be over three hundred million carriers of HBV in the world and probably at least as many hepatitis C virus carriers, and when the World Health Organisation estimates that there have been 17 million infections with human immunodeficiency virus, the lessons learnt around 1945 about the need to use sterile instruments and needles for all injections and venepunctures remain highly pertinent.

摘要

1910年引入静脉注射胂凡纳明治疗梅毒后不久,人们发现该治疗会并发黄疸。其根本原因——注射器和针头未消毒,最终在20世纪40年代初被认识到,这主要归功于英国军队调查人员的努力。最常传播的感染可能是乙型肝炎病毒(HBV),但在胂凡纳明黄疸的几次暴发中出现的高死亡率表明,有时涉及HBV的变异体或其他肝炎病毒。五十年后的今天,据估计世界上有超过三亿HBV携带者,丙型肝炎病毒携带者数量可能至少与之相当,而且世界卫生组织估计已有1700万人感染人类免疫缺陷病毒,1945年左右吸取的关于所有注射和静脉穿刺都需要使用无菌器械和针头的教训仍然极为相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c124/1195466/8ff95f291780/genitmed00014-0049-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c124/1195466/9b898fba3701/genitmed00014-0048-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c124/1195466/8ff95f291780/genitmed00014-0049-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c124/1195466/9b898fba3701/genitmed00014-0048-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c124/1195466/8ff95f291780/genitmed00014-0049-a.jpg

相似文献

1
Arsphenamine jaundice and the recognition of instrument-borne virus infection.胂凡纳明黄疸与器械传播病毒感染的识别
Genitourin Med. 1995 Apr;71(2):109-19. doi: 10.1136/sti.71.2.109.
2
Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections.基于模型对通过不安全注射传播人类免疫缺陷病毒和乙型肝炎病毒风险的估计。
Int J Epidemiol. 1995 Apr;24(2):446-52. doi: 10.1093/ije/24.2.446.
3
Outbreak of viral hepatitis B in a rural community in India linked to inadequately sterilized needles and syringes.印度一个农村社区爆发乙型病毒性肝炎,与针头和注射器消毒不充分有关。
Bull World Health Organ. 1998;76(1):93-8.
4
Transmission of hepatitis B and C viruses in outpatient settings--New York, Oklahoma, and Nebraska, 2000-2002.2000 - 2002年纽约、俄克拉荷马和内布拉斯加州门诊环境中乙型和丙型肝炎病毒的传播情况
MMWR Morb Mortal Wkly Rep. 2003 Sep 26;52(38):901-6.
5
Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.发展中世界通过不安全注射传播的乙型肝炎、丙型肝炎和人类免疫缺陷病毒:基于模型的区域估计数
Bull World Health Organ. 1999;77(10):801-7.
6
Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies.降低免疫规划中不安全注射的风险:各种注射技术的财务和操作影响
Bull World Health Organ. 1995;73(4):531-40.
7
Hepatitis C Contamination of Medication Vials Accessed with Sterile Needles and Syringes.注射器和无菌针头接触的药瓶中丙型肝炎的污染。
Anesthesiology. 2019 Aug;131(2):305-314. doi: 10.1097/ALN.0000000000002772.
8
Unsterile injections and emergence of human pathogens.非无菌注射与人类病原体的出现。
Lancet. 2002 Jun 29;359(9325):2280. doi: 10.1016/S0140-6736(02)09284-X.
9
The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings.医疗机构中安全、合理使用注射剂政策的成本效益
Bull World Health Organ. 2003;81(4):277-85. Epub 2003 May 16.
10
Magic bullet: Paul Ehrlich, Salvarsan and the birth of venereology.神奇子弹:保罗·埃利希、洒尔佛散与性病学的诞生
Sex Transm Infect. 2015 Feb;91(1):68-9. doi: 10.1136/sextrans-2014-051779.

引用本文的文献

1
Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin.乙型肝炎病毒 D 基因型在欧洲和地中海盆地的时空动态。
PLoS One. 2012;7(5):e37198. doi: 10.1371/journal.pone.0037198. Epub 2012 May 25.

本文引用的文献

1
Transmission of Infection during Withdrawal of Blood.采血过程中的感染传播。
Br Med J. 1945 May 5;1(4400):625-6. doi: 10.1136/bmj.1.4400.625.
2
Post-penicillin jaundice.青霉素后黄疸
Br Med J. 1946 Nov 9;2(4479):685-8. doi: 10.1136/bmj.2.4479.685.
3
Infective hepatitis: a problem of world health.传染性肝炎:一个全球健康问题。
Br Med J. 1952 Jun 28;1(4773):1367-71. doi: 10.1136/bmj.1.4773.1367.
4
Infective hepatitis and arsenotherapy hepatitis as it occurred amongst naval personnel in Portsmouth during the 1939-45 War.1939年至1945年战争期间朴茨茅斯海军人员中发生的感染性肝炎和砷剂治疗性肝炎。
J Hyg (Lond). 1953 Jun;51(2):145-56. doi: 10.1017/s0022172400015588.
5
The epidemic of human immunodeficiency virus infection in Romanian children.罗马尼亚儿童中的人类免疫缺陷病毒感染流行情况。
AIDS Res Hum Retroviruses. 1993 Jan;9(1):99-104. doi: 10.1089/aid.1993.9.99.
6
Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation.美国的乙型肝炎病毒前核心区突变与暴发性肝炎。一种基于聚合酶链反应的特定突变检测方法。
J Clin Invest. 1994 Feb;93(2):550-5. doi: 10.1172/JCI117006.
7
Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data.前苏联地区人类免疫缺陷病毒1型的分子流行病学:env V3序列分析及其与流行病学数据的相关性
AIDS. 1994 May;8(5):619-24.
8
Private medical practice and anti-yaws campaigns in South Eastern Nigeria 1925-1950.1925年至1950年尼日利亚东南部的私人医疗实践与抗雅司病运动
Trop Doct. 1980 Jul;10(3):129-32. doi: 10.1177/004947558001000320.
9
Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis--associated antigen.病毒剂量与临床型肝炎潜伏期及肝炎相关抗原出现时间的关系
Am J Med Sci. 1972 Jan;263(1):27-33. doi: 10.1097/00000441-197201000-00005.
10
Studies of Australia-SH antigen in sporadic viral hepatitis in London.伦敦散发性病毒性肝炎中澳大利亚-SH抗原的研究。
Br Med J. 1970 Feb 14;1(5693):403-5. doi: 10.1136/bmj.1.5693.403.